PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19
£100,000 grant to develop a globally-accessible, oral antiviral as part of the COVID Moonshot initiative
Congratulations to all in the COVID-19 Antibody Taskforce on identifying potential therapeutic candidates in such q… https://t.co/KBvYpxBqFO
KQ Labs opens applications for health start-ups for its annual accelerator programme
This year's programme delivered by the Francis Crick Institute and funded by LifeArc
Advise & Connect: LifeArc offers expertise and funding to help tackle COVID-19
Access our advice, network and potentially more
LifeArc and the MND Association commit £1m to boost search for new treatments
Bolstered by the fundraising efforts of Leeds Rhinos’ coach Kevin Sinfield.
Action Medical Research and LifeArc announce joint funding awards for translational research into children’s rare diseases
Third joint funding round of up to £1 million
LifeArc invests in Cumulus Neuroscience
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care
Applications are now open for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs…
Repurposing drugs: the opportunity and the challenges
Catriona Crombie outlines the case studies from our seminar on drug repurposing
LifeArc appoints Dr Linda Bradley to head up business development
Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.